retatrutide mechanism triple agonist glp-1 gip glucagon ly3437943 Retatrutide: How GLP-1/GIP/Glucagon Receptor Agonism Differs From Existing Compounds The Road towards Triple Agonists:
Description
Multiply that across hundreds or thousands of employees, and the financial impact becomes staggering
Am Surg 87(8):12871291
Each 1% reduction in A1c roughly corresponds to an average blood sugar decrease of about 25-30 mg/dL (1.4-1.7 mmol/L), though this varies by individual
These medicines reduce Major Adverse Cardiovascular Events (MACE), cardiovascular death, and chronic kidney disease rates
For other individuals, however, the benefits of improved glycemic control, weight loss, and cardiovascular risk reduction may outweigh theoretical concerns
10.1016/j.cell.2016.05.011 21 YangM
